Abstract
In human immunodeficiency virus (HIV) infection, serum level of zinc, an important micronutrient for immune function, is frequently diminished. The aim of this study was to determine the zinc status in relation to immunological parameters and disease stage in 79 HIV-1 seropositive patients. The median serum level of zinc was within normal limits (12.5 µmol/L) but in 23% of patients, zinc deficiency was seen. Decreased serum zinc was associated with a low CD4 cell count, high viral load, and increased neopterin and IgA levels. According to current treatment recommendations, the majority of patients received antiretroviral triple therapy. Zinc levels in treated and untreated patients were comparable. Referring to disease stage (CDC classification, 1993), the mean zinc level was highest in stage C and lowest in stage A. In conclusion, even under antiretroviral triple therapy, zinc deficiency is still of great importance in HIV infection, and zinc substitution in zinc deficient individuals should be taken into account to optimize therapeutical success.
Article PDF
Similar content being viewed by others
References
S. Cunningham-Rundles, R. S. Bockmann, A. Lin, P. V. Giardina, M. W. Hilgartner, D. Caldwell-Brown, et al., Physiological and pharmacological effects of zinc on immune response, Ann. NY Acad. Sci. 587, 113–122 (1980).
J. F. Bach, The multi-faceted zinc dependency of the immune system, Immunol. Today 4, 225–227 (1981).
N. Wellinghausen, H. Kirchner, and L. Rink, The immunobiology of zinc, Immunol. Today 18, 519–521 (1997).
M. Baum, L. Cassetti, P. Bonvehi, G. Shor-Posner, Y. Lu, and H. Sauberlich, Inadequate dietary intake and altered nutrition status in early HIV-1 infection, Nutrition 10, 16–20 (1994).
M. K. Baum, G. Shor-Posner, Y. Lu, B. Rosner, H. E. Sauberlich, M. A. Fletcher, et al., Micronutrients and HIV-1 disease progression, AIDS 9, 1051–1056 (1995).
J. Koch, E. A. Neal, M. J. Schlott, Y. L. Garcia-Shelton, M. F. Chan, K. E. Weaver, et al., Zinc levels and infection in hospitalized patients with AIDS, Nutrition 12, 515–518 (1996).
R. S. Beach, E. Mantero-Atienza, G. Shor-Posner, J. J. Javier, J. Szapocznik, R. Morgan, et al., Specific nutrient abnormalities in asymptomatic HIV-1 infection, AIDS 6, 701–708 (1992).
T. Harrer, B. Wolf, W. Näger, W. Schwarz, D. Bergner, and J. R. Kalden, In vitro activation of peripheral mononuclear cells by zinc in HIV-infected patients and healthy controls, Clin. Exp. Immunol. 89, 285–289 (1992).
C. Allavena, B. Dousset, T. May, F. Dubois, P. Canton, and F. Belleville, Relationship of trace element, immunological markers and HIV1 infection progression, Biol. Trace Element Res. 47, 133–138 (1995).
M. K. Baum and G. Shor-Posner, Micronutrient status in relationship to mortality in HIV-1 disease, Nutr. Rev. 56, 135–139 (1998).
M. K. Baum, G. Shor-Posner, S. Lai, G. Zhang, H. Lai, M. A. Fletcher, et al., High risk of hIV-related mortality is associated with selenium deficiency, J. Acquir. Immune Defic. Syndr. 15, 370–374 (1997).
M. Egger, B. Hirschel, P. Francioli, P. Sudre, M. Wirz, M. Flepp, et al., Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort study, Br. Med. J. 315, 1194–1199 (1997).
C. C. Carpenter, M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, et al., Antiretroviral therapy for HIV infection in 1996. Updated recommendations of the International AIDS Society—USA, JAMA 277, 1962–1969 (1997).
Centers for Disease Control, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR 41, 1–19 (1992).
K. W. Beck, P. Schramel, A. Hedl, H. Jager, and W. Kaboth, Serum trace element levels in HIV-infected subjects, Biol. Trace Element Res. 25, 89–96 (1990).
L. Isa, A. Lucchini, S. Lodi, and M. Giachetti, Blood zinc status and zinc treatment in human immunodeficiency virus-infected patients, Int. J. Clin. Lab. Res. 22, 45–47 (1992).
N. Wellinghausen, W. Jöchle, S. Reuter, W. A. Flegel, A. Grünert, and P. Kern, Zinc status in patients with alveolar echinococcosis is related to disease progression, Parasite Immunol. 21, 237–241 (1999).
J. M. Zeller, N. L. McCain, and B. Swanson, Immunological and virological markers of HIV disease progression, JANAC 7, 15–27 (1996).
C. M. Tsoukas and N. F. Bernard, Markers predicting progression of human immunodeficiency virus-related disease, Clin. Microbiol. Rev. 7, 14–28 (1994).
B. Melichar, R. Zangerle, E. Artner-Dworzak, H. Wachter, and D. Fuchs, Are disturbances of zinc metabolism in human immunodeficiency virus type 1 (HIV-1) infection caused by immune activation? Pteridines 4, 195–199 (1993).
A. D. Frankel and J. A. Young, HIV-1: fifteen proteins and an RNA, Annu. Rev. Biochem. 67, 1–25 (1998).
J. Kushner, The phenomenon of the acute phase response, Ann. NY Acad. Sci. 389, 39–48 (1982).
A. Singh, B. L. Smoak, K. Y. Patterson, L. G. LeMay, C. Veillon, and P. A. Deutster, Biochemical indices of selected trace elements and minerals in men: effect of stress, Am. J. Clin. Nutr. 53, 126–131 (1991).
E. Mocchegiani, S. Veccia, F. Ancarani, G. Scalise, and N. Fabris, Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) treatment against opportunistic infection in AIDS, Int. J. Immunopharmacol. 17, 719–727 (1995).
A. M. Tang, N. M. H. Graham, and A. J. Saah, Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection, Am. J. Epidemiol. 143, 1244–1256 (1996).
R. K. Chandra, Excessive intake of zinc impairs immune responses, J. Am. Med. Assoc. 252, 1443–1446 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wellinghausen, N., Kern, W.V., Jöchle, W. et al. Zinc serum level in human immunodeficiency virus-infected patients in relation to immunological status. Biol Trace Elem Res 73, 139–149 (2000). https://doi.org/10.1385/BTER:73:2:139
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:73:2:139